乳腺密度的变化与激素替代疗法的开始,停止和持续使用有关
C M Rutter1, M T Mandelson, M B Laya
1Group Health Cooperative of Puget Sound, Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA. rutter.c@ghc.org
JAMA
|February 15, 2001
概括
激素替代疗法 (HRT) 的启动会增加乳腺密度,而停止治疗会减少乳腺密度. 乳腺密度的这些动态变化与绝经后妇女使用HRT有关.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
背景情况:
- 众所周知,激素替代疗法 (HRT) 可以增加乳腺密度.
- 乳腺密度增加与乳房摄影敏感度降低有关.
- 缺乏关于HRT停止和延续对乳腺密度的影响的系统研究.
研究的目的:
- 调查启动,停止和继续HRT对乳腺密度的影响.
- 分析接受HRT的绝经后妇女的乳腺密度变化.
- 提供HRT与乳腺密度之间的动态关系的数据.
主要方法:
- 一项观察性队列研究,涉及5212名绝经后妇女.
- 从1996年至1998年间从查性乳房镜片中收集的数据.
- 使用BI-RADS尺度评估乳腺密度,将HRT使用者 (发起者,停止者,继续者) 与非使用者进行比较.
主要成果:
- 开始HRT显著增加了乳腺密度 (RR,2.57).
- 停止HRT与乳腺密度降低有关 (RR,1.81).
- 持续使用HRT显示密度增加 (RR, 1.33) 和持续高密度 (RR, 1.45).
结论:
- 与HRT相关的乳腺密度变化是动态的.
- 开始HRT会导致乳腺密度增加.
- 停止HRT导致乳腺密度下降.
相关概念视频
Bone Remodeling
34.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
34.4K
Bone Disorders
8.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K
Target Cell Response to Hormones
5.6K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.6K
Hormonal Regulation of the Menstrual Cycle
2.4K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
2.4K
Menopause
5.0K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.0K
Cellular Adaptation III: Hyperplasia
55
Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimuli such as injury, hormones, or stress, involving mitosis to produce genetically identical cells and support tissue repair and regeneration.Tissue CapacityCertain tissues, including the epidermis, intestinal epithelium, bone marrow, and fibroblasts, have a high potential for hyperplasia. Others, such as bone, cartilage, and smooth muscle, show...
55


